Ivermectin Injection 1% is a veterinary antiparasitic injection containing 10 mg of ivermectin per mL. The Ivermectinkart listing describes it for cattle and swine, while current veterinary labeling supports treatment and control of specified gastrointestinal worms, lungworms, lice, mites and, in cattle, certain grub infestations. It is administered by the subcutaneous route, not intravenously or intramuscularly.

This product should not be confused with human ivermectin tablets or other human formulations. Manufacturer and supplied pack information are not disclosed on the current Ivermectinkart listing, so those details should be verified from the actual product packaging before administration.

Product Details	Information
Active Ingredient	Ivermectin
Indication	Veterinary treatment and control of specified internal and external parasites in cattle and swine
Manufacturer	Not verified for the Ivermectinkart listing
Packaging	Not verified for the Ivermectinkart listing
Strength	1% w/v (10 mg/mL) injection. CDSCO records also document a separate 10% w/v ivermectin concentrate; this is not the same dosage form.
Delivery Time	10–13 days

Ivermectin Injection 1%

Name: Ivermectin Injection 1%
Brand: Ivermectinkart
Price: 60 USD
Availability: InStock

$60.00

Pack Size

Quantity

Ivermectin 1% injection is intended for veterinary parasite control rather than human treatment. Label-supported uses include:

Cattle: gastrointestinal roundworms, lungworms, cattle grubs, sucking lice and specified mange mites.

Swine: gastrointestinal roundworms, lungworms, lice and mange mites.

Certain labels also provide special minor-use directions for reindeer and American bison.

The specific parasite species covered can vary by product label, country and animal species, so the supplied label should be checked before treatment.

The Ivermectinkart listing specifically identifies cattle and swine as the intended animals.
Ivermectin belongs to the macrocyclic lactone class of antiparasitic medicines. It acts primarily on chloride channels in parasites, increasing chloride-ion permeability and disrupting nerve and muscle activity. This produces paralysis and death of susceptible parasites.

The important practical point is that ivermectin does not treat every parasite and resistance can develop. Veterinary parasite-control programs should therefore be based on the animals involved, local parasite patterns, diagnostic findings and previous treatment response rather than repeated routine dosing without assessment.
The exact dose must be selected from the specific veterinary label and the animal's current body weight. Current U.S. 1% ivermectin injection labeling provides these general reference rates:

Animal Label-based ivermectin dose Route

Cattle 200 micrograms/kg; equivalent to 1 mL/50 kg Subcutaneous

Swine 300 micrograms/kg; equivalent to 1 mL/33 kg Subcutaneous

These are general label rates, not individualized treatment instructions. Animals should be appropriately restrained and dosing should be performed by, or under the direction of, a veterinarian or appropriately trained animal-health professional. Do not inject intravenously or intramuscularly.
Safe administration depends on following the supplied product label and maintaining proper injection technique.

Confirm the animal species, current body weight, product concentration and expiry date before treatment.

Use clean, sterile equipment and disinfect the injection site as directed.

For cattle, the labeled route is subcutaneous under the loose skin in front of or behind the shoulder.

For swine, the labeled route is subcutaneous in the neck, immediately behind the ear.

Never substitute a 1% veterinary injection for a human ivermectin formulation or calculate a human dose from this product.
Food-producing animals require particular attention to withdrawal periods. For one current FDA-labeled 1% ivermectin injection, cattle should not be slaughtered within 35 days of treatment and swine should not be slaughtered within 18 days. The label also states that a milk withdrawal time has not been established, so it should not be used in female dairy cattle of breeding age under that labeling. Always follow the withdrawal period printed on the exact product supplied.

Store according to the product label; one current label specifies 15–30°C and protection from light.

Opened multidose containers have specific puncture/use limits that vary by product.

Underdosing can reduce treatment effectiveness and encourage parasite resistance.

Veterinary diagnosis and monitoring, including appropriate fecal testing where indicated, can help determine whether treatment remains effective.
This product is for veterinary use and is not for humans. Current FDA/DailyMed labeling explicitly warns against human use. Keep the injection and administration equipment away from children.

Do not administer it to an animal species unless that species is specifically covered by the product's label. Some ivermectin injection products are developed specifically for cattle, swine and certain additional species; serious adverse reactions, including fatalities in dogs, can occur when unsuitable products are used in other species.

Subcutaneous injection can cause temporary discomfort or swelling. Injection-site infection, including potentially serious clostridial infection in cattle, requires prompt veterinary attention. Avoid IV or IM administration. Proper restraint, sterile equipment and correct injection technique are important.

Observe all meat, milk and animal-specific withdrawal restrictions. Do not rely on withdrawal periods from another ivermectin product because formulations and labeling can differ. Also consider parasite resistance when deciding whether treatment is appropriate.

This information is for general education and does not replace advice from a doctor, pharmacist or qualified healthcare professional.